HOUSTON METHODIST IMAGE: IMMUNE CELLS POSITIVE FOR A PROTEIN, S100A4 (IN GREEN) COULD BE A POTENTIAL THERAPEUTIC TARGET FOR RESTORING ANTITUMOR ACTION OF IMMUNE CELLS TOWARD GLIOBLASTOMAS. CREDIT: HOUSTON METHODIST HOUSTON-(April 5, 2022) – Houston Methodist researchers have identified the genetic and molecular fingerprints of different cancer and immune cells in glioblastoma, the deadliest and most common...
